BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 898 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $200,700 | -21.7% | 6,000 | 0.0% | 0.04% | -22.2% |
| Q1 2024 | $256,440 | +10.6% | 6,000 | 0.0% | 0.04% | +2.3% |
| Q4 2023 | $231,960 | +2.4% | 6,000 | 0.0% | 0.04% | -4.3% |
| Q3 2023 | $226,440 | -17.2% | 6,000 | 0.0% | 0.05% | -13.2% |
| Q2 2023 | $273,360 | +12.3% | 6,000 | 0.0% | 0.05% | +8.2% |
| Q1 2023 | $243,360 | -20.4% | 6,000 | 0.0% | 0.05% | -21.0% |
| Q4 2022 | $305,820 | -5.3% | 6,000 | 0.0% | 0.06% | -12.7% |
| Q3 2022 | $323,000 | -16.1% | 6,000 | 0.0% | 0.07% | -10.1% |
| Q2 2022 | $385,000 | -17.2% | 6,000 | 0.0% | 0.08% | -2.5% |
| Q1 2022 | $465,000 | -9.7% | 6,000 | 0.0% | 0.08% | -3.6% |
| Q4 2021 | $515,000 | +6.6% | 6,000 | 0.0% | 0.08% | 0.0% |
| Q3 2021 | $483,000 | 0.0% | 6,000 | 0.0% | 0.08% | +2.4% |
| Q2 2021 | $483,000 | -4.5% | 6,000 | 0.0% | 0.08% | -11.8% |
| Q1 2021 | $506,000 | +5.2% | 6,000 | 0.0% | 0.09% | -3.1% |
| Q4 2020 | $481,000 | -0.4% | 6,000 | 0.0% | 0.10% | -11.9% |
| Q3 2020 | $483,000 | -6.6% | 6,000 | 0.0% | 0.11% | -14.2% |
| Q2 2020 | $517,000 | +6.2% | 6,000 | 0.0% | 0.13% | -11.2% |
| Q1 2020 | $487,000 | -3.0% | 6,000 | 0.0% | 0.14% | +31.2% |
| Q4 2019 | $502,000 | -4.4% | 6,000 | 0.0% | 0.11% | -9.9% |
| Q3 2019 | $525,000 | +6.9% | 6,000 | 0.0% | 0.12% | +6.1% |
| Q2 2019 | $491,000 | +0.6% | 6,000 | 0.0% | 0.11% | -3.4% |
| Q1 2019 | $488,000 | +23.5% | 6,000 | 0.0% | 0.12% | +8.3% |
| Q4 2018 | $395,000 | -14.7% | 6,000 | 0.0% | 0.11% | +4.8% |
| Q3 2018 | $463,000 | +4.5% | 6,000 | 0.0% | 0.10% | +1.0% |
| Q2 2018 | $443,000 | +5.2% | 6,000 | 0.0% | 0.10% | +4.0% |
| Q1 2018 | $421,000 | +8.5% | 6,000 | 0.0% | 0.10% | +10.0% |
| Q4 2017 | $388,000 | +3.2% | 6,000 | 0.0% | 0.09% | -1.1% |
| Q3 2017 | $376,000 | +3.6% | 6,000 | 0.0% | 0.09% | +1.1% |
| Q2 2017 | $363,000 | +16.7% | 6,000 | 0.0% | 0.09% | +13.9% |
| Q1 2017 | $311,000 | +16.9% | 6,000 | 0.0% | 0.08% | +9.7% |
| Q4 2016 | $266,000 | -7.0% | 6,000 | 0.0% | 0.07% | -10.0% |
| Q3 2016 | $286,000 | +5.5% | 6,000 | 0.0% | 0.08% | +1.3% |
| Q2 2016 | $271,000 | +18.3% | 6,000 | 0.0% | 0.08% | +14.5% |
| Q1 2016 | $229,000 | 0.0% | 6,000 | 0.0% | 0.07% | 0.0% |
| Q4 2015 | $229,000 | -45.5% | 6,000 | 0.0% | 0.07% | -36.1% |
| Q2 2015 | $420,000 | +2.2% | 6,000 | 0.0% | 0.11% | +2.9% |
| Q1 2015 | $411,000 | -6.6% | 6,000 | 0.0% | 0.10% | -7.9% |
| Q4 2014 | $440,000 | +2.1% | 6,000 | 0.0% | 0.11% | -0.9% |
| Q3 2014 | $431,000 | -0.7% | 6,000 | 0.0% | 0.12% | +2.7% |
| Q2 2014 | $434,000 | -1.6% | 6,000 | 0.0% | 0.11% | -5.9% |
| Q1 2014 | $441,000 | +5.8% | 6,000 | 0.0% | 0.12% | +0.8% |
| Q4 2013 | $417,000 | +5.8% | 6,000 | 0.0% | 0.12% | -3.3% |
| Q3 2013 | $394,000 | -5.3% | 6,000 | 0.0% | 0.12% | -8.3% |
| Q2 2013 | $416,000 | – | 6,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 16,850,000 | $1,473,870,000 | 17.51% |
| SECTOR GAMMA AS | 472,305 | $41,313,000 | 6.98% |
| TSFG, LLC | 91,132 | $7,971,000 | 6.10% |
| Veritas Asset Management LLP | 6,386,849 | $558,658,000 | 5.44% |
| Palmer Knight Co | 64,636 | $5,654,000 | 4.80% |
| Triodos Investment Management BV | 193,700 | $16,943,000 | 4.30% |
| Progressive Investment Management Corp | 82,216 | $7,191,000 | 3.85% |
| Alphinity Investment Management Pty Ltd | 362,173 | $31,679,000 | 3.65% |
| HealthCor Management, L.P. | 1,032,820 | $90,341,000 | 3.42% |
| Sivik Global Healthcare LLC | 75,000 | $6,560,000 | 3.31% |